Low frequency of GB virus C viremia in a cohort of HIV-1-infected elite suppressors

AIDS

Volumn 22, Issue 17, 2008, Pages 2398-2400

  Blankson, Joel N ^a   Klinzman, Donna ^b   Astemborski, Jacquie ^a,c   Thomas, David L ^a,c   Kirk, Gregory D ^a,c   Stapleton, Jack T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MIXED INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; VIREMIA; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CD4 LYMPHOCYTE COUNT; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; VIRAL LOAD; VIREMIA;

EID: 56549092643     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328316c3fb     Document Type: Article

References (14)

1. Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 2007; 3:406-416.
2. Sáez-Cirión A, Pancino G, Sinet M, Venet A, Lambotte O. HIV controllers: how do they tame the virus? Trends Immunol 2007; 28:532-540.
3. Zhang W, Chaloner K, Tillmann HL, Williams CF, Stapleton JT. Effect of early and late GBV-C viremia on survival of HIV infected individuals: a meta-analysis. HIV Med 2006; 7:173-180.
4. Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1α, MIP-1β, and SDF-1. Lancet 2004; 363:2040-2046.
5. Jung S, Knauer O, Donhauser N, Eichenmuller M, Helm M, Fleckenstein B, et al. Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors. AIDS 2005; 19:12567-21272.
6. Souza IE, Allen JB, Xiang J, Klinzman D, Diaz R, Zhang S, et al. Optimal testing for GB virus C viremia: effect of primer selection on estimates of GBV-C prevalence and response to antiretroviral therapy. J Clin Microbiol 2006; 44:3105-3113.
7. Stapleton JT. GB virus type C/hepatitis G virus. Semin Liver Dis 2003; 23:137-148.
8. Williams CF, Klinzman D, Yamashita TE, Xiang J, Polgreen PM, Rinaldo C, et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 2004; 350:981-990.
9. Bjorkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, Widell A. GB Virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 2004; 18:877-886.
10. Van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JMA, et al. GB Virus C coinfection and HIV-1 disease progression: the Amsterdam cohort study. J Infect Dis 2005; 191:678-685.
11. Tacke M, Schmolke S, Schlueter V, Sauleda S, Esteban Jl, Tanaka E, et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997; 26:1626-1633.
12. Xiang J, Wunschmann S, Schmidt WN, SHao J, Stapleton JT. Full-length GB Virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positiveT cells. J Virol 2000; 74:9125-9133.
13. George SL, Varmaz D, Stapleton JT. GB virus C replicates in primary T and B lymphocytes. J Infect Dis 2006; 193:451-454.
14. Klinzman D, Katz L, George SL, Chang Q, Xiang J, Zdunek D, et al. GB virus C/hepatitis G virus: does clearance of viremia differ based on mode of transmission? In: GEVKBCCE. Edited by Jilbert AR. Melbourne: Australian Center for Hepatitis Virology; 2004. pp. 488-490.